Physicians committed to patient safety and comfort.

2020 Annual Conference

Registration is now closed.


Our highest priority is the health, safety, and well-being of our MSA members and the communities they serve.

In light of the magnitude of the looming COVID-19 spread and the steady stream of recommendations to limit non-essential travel and group gatherings, after careful deliberation, the Executive Committee of the MSA has decided to reschedule the MSA Annual Conference, to be held virtually on September 19, 2020. Registration will open soon. We look forward to "seeing" you soon.

Kyle Bohman, MD and Tae Kim, MD
MSA Annual Meeting Program Chair and Co-Chair

Event Details

Saturday, September 19, 2020 - 7:00am
Saturday, September 19, 2020 - 12:45pm
Virtual Meeting


Saturday September 19, 2020

7:55-8:00am: Welcome Remarks
J. Kyle Bohman, MD, Mayo Clinic, Program Chair
Tae Kim, MD, University of Minnesota, Pediatric Program Chair

8:00-8:25am: Challenges of Patients on Naltrexone or Buprenorphine
Dustin Palm, MD, Minneapolis VA Medical Center

8:25-8:55pm: Opioids: Regulations, Legislation and Education
Julie Cunningham, PharmD, Mayo Clinic

8:55-9:15am: Question & Answer Panel

9:15-9:40am: APSF Update on COVID-19
Mark Warner, MD, Mayo Clinic

9:40-10:10am: COVID-19 ICU management: a crash course for Anesthesiologists
Arun Jayaraman, MD, PhD, Mayo Clinic, Arizona

10:10-10:25am: Question & Answer Panel

10:25-10:55am: Neuroanesthesia – Year in Review
Jeff Pasternak, MD, Mayo Clinic

10:55-11:35am: Safe Opioid Prescription Practices
Alaa Abd-Elsayed, MD, MPH, Medical Director UW Pain Clinic, University of Wisconsin-Madison

11:35-11:50am: Question & Answer Panel

11:50-12:00pm: ASA Update
James Kelly, MD, ASA Board of Directors

12:00-12:30pm Legislative Update
Nate Mussell, JD, Lockridge Grindal Nauen

12:30-12:45pm Final Q&A and Closing Remarks


In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Minnesota Society of Anesthesiologists. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this virtual live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABA MOCA 2.0® Credit
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA) program, known as MOCA 2.0®. Please consult the ABA website,, for a list of all MOCA 2.0® requirements. Maximum of 4.50 hours available. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

Best Practices in Prescribing Opioids and Controlled Substances
Learners are responsible for reporting continuing education credits to the Board of Medical Practice either via email at or by mail to: Minnesota Board of Medical Practice, ATTN: Opioid CE, 2829 University Avenue SE, Suite 500, Minneapolis, MN 55414. Reporting must be done between January 1, 2020 and December 31, 2022. Please see the requirements found HERE